Chimeric Antigen Receptor T-cells (CAR-T) therapy
Sponsors
Fondazione Italiana Linfomi - ETS
Conditions
Diffuse Large B Cell Lymphoma (DLBCL)High Grade B Cell LymphomaNon-hodgkin Lymphoma,B CellPrimary Mediastinal B-cell Lymphoma (PMBCL)
Unknown Phase
SARcopenia and Simplified Geriatric Assessment in Lymphoma Patients Undergoing CAR-T Cell Therapy: the FIL_SAR-CAR Project
RecruitingNCT06156774
Start: 2024-04-18End: 2026-07-31Target: 130Updated: 2025-12-08
Neurocognitive Assessment in Adults Undergoing CD19 Targeted CAR-T Cell Therapy
Not yet recruitingNCT07463781
Start: 2026-05-01End: 2029-05-01Target: 100Updated: 2026-03-13